Cas:1353973-90-6 [1-(4-Methoxy-benzyl)-piperidin-4-yl]-Methyl-aMine hydrochloride manufacturer & supplier

Chemical Name:[1-(4-Methoxy-benzyl)-piperidin-4-yl]-Methyl-aMine hydrochloride

CAS.NO:1353973-90-6

Synonyms:[1-(4-Methoxy-benzyl)-piperidin-4-yl]-Methyl-aMine hydrochloride

Molecular Formula:C₁₄H₂₃ClN₂O

Molecular Weight:270.79822

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like [1-(4-Methoxy-benzyl)-piperidin-4-yl]-Methyl-aMine hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,[1-(4-Methoxy-benzyl)-piperidin-4-yl]-Methyl-aMine hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,[1-(4-Methoxy-benzyl)-piperidin-4-yl]-Methyl-aMine hydrochloride Use and application,[1-(4-Methoxy-benzyl)-piperidin-4-yl]-Methyl-aMine hydrochloride technical grade,usp/ep/jp grade.

Related News: The entire set of results “strongly support” the Darzalex-Rd combo as a new standard of care for newly diagnosed, transplant-ineligible multiple myeloma patients, Thierry Facon, M.D., an investigator of the MAIA trial, said in a statement. [1-(4-Methoxy-benzyl)-piperidin-4-yl]-Methyl-aMine hydrochloride manufacturer The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy. [1-(4-Methoxy-benzyl)-piperidin-4-yl]-Methyl-aMine hydrochloride supplier The entire set of results “strongly support” the Darzalex-Rd combo as a new standard of care for newly diagnosed, transplant-ineligible multiple myeloma patients, Thierry Facon, M.D., an investigator of the MAIA trial, said in a statement. [1-(4-Methoxy-benzyl)-piperidin-4-yl]-Methyl-aMine hydrochloride vendor The United States has suspended imports of dogs from more than 100 countries where there’s a high rabies risk. [1-(4-Methoxy-benzyl)-piperidin-4-yl]-Methyl-aMine hydrochloride factory The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.